224 related articles for article (PubMed ID: 11104386)
1. Stratified tests, stratified slopes, and random effects models for clinical trials with missing data.
Dawson JD; Han SH
J Biopharm Stat; 2000 Nov; 10(4):447-55. PubMed ID: 11104386
[TBL] [Abstract][Full Text] [Related]
2. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
Sullivan LM; D'Agostino RB
Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
[TBL] [Abstract][Full Text] [Related]
3. Impact of missing data on type 1 error rates in non-inferiority trials.
Yoo B
Pharm Stat; 2010; 9(2):87-99. PubMed ID: 19408241
[TBL] [Abstract][Full Text] [Related]
4. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
Siddiqui O; Hung HM; O'Neill R
J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
[TBL] [Abstract][Full Text] [Related]
5. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
6. Tests for homogeneity of the risk difference when data are sparse.
Lipsitz SR; Dear KB; Laird NM; Molenberghs G
Biometrics; 1998 Mar; 54(1):148-60. PubMed ID: 9544513
[TBL] [Abstract][Full Text] [Related]
7. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
Siddiqui O
J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
[TBL] [Abstract][Full Text] [Related]
8. The appropriateness of the Wilcoxon test in ordinal data.
Hilton JF
Stat Med; 1996 Mar; 15(6):631-45. PubMed ID: 8731005
[TBL] [Abstract][Full Text] [Related]
9. Test homogeneity of risk difference across subgroups in clinical trials.
Zhang L; Yang H; Cho I
J Biopharm Stat; 2009; 19(1):67-76. PubMed ID: 19127467
[TBL] [Abstract][Full Text] [Related]
10. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
Hou Y; Ding V; Li K; Zhou XH
J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
[TBL] [Abstract][Full Text] [Related]
11. Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.
Ahn C; Tonidandel S; Overall JE
J Biopharm Stat; 2000 May; 10(2):265-86. PubMed ID: 10803729
[TBL] [Abstract][Full Text] [Related]
12. Sample size calculations with multiplicity adjustment for longitudinal clinical trials with missing data.
Lu K
Stat Med; 2012 Jan; 31(1):19-28. PubMed ID: 22162151
[TBL] [Abstract][Full Text] [Related]
13. Testing for interaction in two-way random and mixed effects models: the fully nonparametric approach.
Gaugler T; Akritas MG
Biometrics; 2011 Dec; 67(4):1314-20. PubMed ID: 21401567
[TBL] [Abstract][Full Text] [Related]
14. An overview of practical approaches for handling missing data in clinical trials.
DeSouza CM; Legedza AT; Sankoh AJ
J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.
Chen YF; Yang Y; Hung HM; Wang SJ
Contemp Clin Trials; 2011 Jul; 32(4):592-604. PubMed ID: 21540126
[TBL] [Abstract][Full Text] [Related]
16. Sample size for testing difference between two proportions for the bilateral-sample design.
Qiu SF; Tang NS; Tang ML; Pei YB
J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
[TBL] [Abstract][Full Text] [Related]
17. Stratified testing for treatment effects with missing data.
Shih WJ; Quan H
Biometrics; 1998 Jun; 54(2):782-7. PubMed ID: 9660633
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
19. Power approximation for the van Elteren test based on location-scale family of distributions.
Zhao YD; Qu Y; Rahardja D
J Biopharm Stat; 2006; 16(6):803-15. PubMed ID: 17146980
[TBL] [Abstract][Full Text] [Related]
20. Wilcoxon-Mann-Whitney test: stratify or not?
Qu Y; Zhao YD; Rahardja D
J Biopharm Stat; 2008; 18(6):1103-11. PubMed ID: 18991110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
